ICON Insights
BioPharma companies and Medical Device manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.
Thought leadership
- Transforming TrialsThe traditional clinical development model needs to change.
- Value Based DevelopmentThe traditional healthcare delivery model is changing.
- Digital DisruptionTechnologies that accelerate and improve Clinical Trials.
- Patient CentricityPatients are now better informed on clinical options than they ever have been.
Transforming Trials
The traditional clinical development model needs to change.
Value Based Development
The traditional healthcare delivery model is changing.
Digital Disruption
Technologies that accelerate and improve Clinical Trials.
Patient Centricity
Patients are now better informed on clinical options than they ever have been.
Insight topics
US payers’ reliance on patient-reported outcomes in coverage decisions
Current views and future outlook.
Challenges and opportunities in traumatic brain injury clinical trials
From identifying biomarkers to improving clinical trial efficiency.
Agile clinical monitoring
The flexibility to keep your trials on track.
Patient centricity in orphan drug development
An analysis of formal patient involvement in the development of drugs for rare diseases.
Mitigating the impact of COVID-19 on cardiovascular trials
Ensure patient safety and trial integrity during a global pandemic.
Patient Centricity
Exploring the patient dynamic from different perspectives.
Advancing digital endpoints
An end-to-end approach to managing wearable devices through clinical development.
Biostatistics - Bringing clarity and focus to the research question: the role of estimands
Find out more about estimands and how deploying this approach will improve the quality of clinical research.
COVID-19: Navigating global market access requirements
Insights to maximise HTA success.
Patient Voice Survey - Decentralised and hybrid trials
The patient perspective.
Pandemic respiratory vaccine clinical trials
Best practices to accelerate operations while the world waits.
Decentralised and hybrid trials
ICON conducted a survey through its Global Site Network to get the patient view.
Payers’ perspectives on digital therapeutics
In-depth interviews reveal what manufacturers can expect from US payers.
Outsourced pharmacovigilance affiliate solution
Why outsourcing pharmacovigilance make sense at an affiliate level
Reimagining Patient-Centricity with the Internet of Medical Things (IoMT)
Discover how emerging technologies can increase clinical trial efficiency
How Digital Technologies will Transform R&D Productivity
Harnessing the power of digital technologies.
Increasing Complexity and Declining ROI in Drug Development
Perspectives from senior pharma executives
Flow Cytometry for Driving Trials Forward
Engage assay experts with unparalleled experience and expertise
Impact of Artificial Intelligence on Outcomes Based Contracting
Understanding the challenges for formulary decision makers and manufacturer
Key Considerations in Chronic Pain Clinical Trials
Determine the right design, assessments and endpoints in your pain study
MDR/IVDR brings higher costs and bottlenecks
Develop the right business strategy to successfully navigate MDR/IVDR
The Role of ICER as an Independent HTA Organisation
primary research evaluating ICER’s influence over payers and manufactures
Drug Safety Reporting
Increasing efficiency through automation
Personalising Digital Health
Develop an integrated, patient centric approach to harnessing Digital Health technologies
Making Sense of the Biosimilars Market
Get the insights you need for successful biosimilar commercialisation
Investigator Payments
Global Investigator Payments Solutions
Regulatory Intelligence Newsletter
ICON’s monthly Regulatory Intelligence Newsletter
CDISC Data Standardisation
Legacy Data Conversion
Wearables
Remote monitoring and leveraging wearable devices and sensors in clinical trials.
Adaptive Design: The Faster Path to Market
An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.